SCHEMBL19729705

SCHEMBL19729705

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5ccccc5)c4-n4c5ccccc5c5ccccc54)c3-n3c4ccccc4c4ccccc43)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HSD17B10 Q99714 1/20 0.38
PRKDC P78527 2/20 0.36
PTGER1 P34995 1/20 0.36
PTGER4 P35408 1/20 0.36
PTGER3 P43115 1/20 0.36
PTGER2 P43116 1/20 0.36
ASH1L Q9NR48 4/20 0.36
HTR6 P50406 2/20 0.35
DUSP3 P51452 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
KMO O15229 1/20 0.33
MAOA P21397 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19075903 0.91 L3MBTL1 (0.48) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL12854048 0.90 L3MBTL1 (0.47) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL19729653 0.89 L3MBTL1 (0.50) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL26720050 0.88 L3MBTL1 (0.42) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL19729718 0.88 TNF (0.44) MAPK14DUSP3MAOA
SCHEMBL26720047 0.86 L3MBTL1 (0.43) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL19729664 0.86 ATM (0.40) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL19729717 0.86 MAPK14 (0.38) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL19729672 0.86 L3MBTL1 (0.46) MAPK14KDM4EATML3MBTL1HSD17B10
SCHEMBL19075905 0.85 L3MBTL1 (0.53) MAPK14KDM4EATML3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10957862-B2 Condensed cyclic compound for organic light-emitting device, and organic light-emitting device including the compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-03-23 US disclosed
US-20170365796-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-12-21 US disclosed
US-20170365796-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365796-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 MAPK14 3901/4885KDM4E 2960/4885ATM 1582/4885
US-10957862-B2 Condensed cyclic compound for organic light-emitting device, and organic light-emitting device including the compound CRY1, CRY2, OCIAD1 MAPK14 3965/4885KDM4E 3510/4885ATM 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.